Search Results 41-50 of 16044 for SC

  1. Sickle cell anemia - Diagnosis & treatment - Mayo Clinic

    Learn about the symptoms, causes and treatment of this inherited blood disorder that, in the United States, is more common among Black people.

  2. Publications - Kaitlin M. Moran, M.D. - Mayo Clinic

    Diaz-Cortes H, Hedges MS, Pacheco-Spann LM, Findley V, Leyva SC, Moran KM, DeStephano CC, Li Z, Colon-Otero G. A feasibility study assessing knowledge ...

  3. Clinical trials - Oncology (Medical)

    ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

  4. Lymphoma Biostatistics and Data Science: Matthew J. Maurer - Mayo Clinic Research

    Maurer, Sc.D., M.S., the Lymphoma Biostatistics and Data Science Laboratory at Mayo Clinic uses analytic methods to advance scientific understanding about ...

  5. Lymphoma Biostatistics and Data Science: Matthew J. Maurer - Overview

    Maurer, Sc.D., M.S., the Lymphoma Biostatistics and Data Science Laboratory at Mayo Clinic uses analytic methods to advance scientific understanding about ...

  6. Collaborators - Lymphoma Biostatistics and Data Science: Matthew J. Maurer - Mayo Clinic Research

    Matthew J. Maurer, Sc.D., M.S., and his colleagues at Mayo Clinic work with collaborators from around the world.

  7. Sumatriptan (subcutaneous route) - Mayo Clinic

    Sumatriptan injection is used to treat acute migraine attacks and cluster headaches in adults. Sumatriptan works in the brain to relieve the pain from migraine ...

  8. Denosumab (subcutaneous route) - Side effects & uses - Mayo Clinic

    Denosumab injection is used to treat osteoporosis (thinning of the bones) in women who have an increased risk for fractures after menopause, and osteoporosis in ...

  9. A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations - Mayo Clinic

    The purpose of this study is to assess the patient's preference for nivolumab subcutaneous (SC) or nivolumab + relatlimab fixed-dose combination (FDC) SC and ...

  10. Publications - Gretchen E. Ames, Ph.D. - Mayo Clinic

    Ames SC, Lange L, Ames GE, Heckman MG, White LJ, Roy V, Foran JM. A prospective study of the relationship between illness perception, depression, anxiety ...